http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104955516-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate | 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104955516-B |
| titleOfInvention | Prolonged buprenorphine transdermal delivery compositions and methods of use |
| abstract | Aspects of the invention include an extended transdermal delivery device for delivering buprenorphine to a subject for an extended period of time, wherein the transdermal delivery device comprises buprenorphine, an alpha-hydroxy acid, and a pressure-sensitive adhesive mixture. In some cases, the buprenorphine, the alpha-hydroxy acid, and the pressure sensitive adhesive are provided as a single matrix layer formulation. Also provided are methods of using the subject elongated transdermal delivery devices, as well as kits comprising the elongated transdermal delivery devices. |
| priorityDate | 2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.